Sign In
Buy CRSP
$52.08
+0.0600 (+0.115%)
At Close: Jun 03, 2026
Crispr Therapeutics' Bright Future Is Coming Into Focus (Rating Upgrade)
08:00am, Monday, 14'th Jul 2025
Curing disease, as opposed to just masking symptoms, is a big deal. CRISPR Therapeutics aims to cure by editing problem genes. So CRSP is the future of medicine! This approach can be too futuristic fo
CRISPR Therapeutics AG (CRSP) Is a Trending Stock: Facts to Know Before Betting on It
10:00am, Friday, 11'th Jul 2025
CRISPR Therapeutics (CRSP) has received quite a bit of attention from Zacks.com users lately. Therefore, it is wise to be aware of the facts that can impact the stock's prospects.
CRISPR Therapeutics (CRSP) Moves 9.6% Higher: Will This Strength Last?
05:26am, Thursday, 10'th Jul 2025
CRISPR Therapeutics (CRSP) saw its shares surge in the last session with trading volume being higher than average. The latest trend in earnings estimate revisions may not translate into further price
10 Monster Stocks to Hold for the Next 10 Years
07:05am, Tuesday, 08'th Jul 2025
When picking new stocks for your portfolio, your best bet is looking for companies that you can hold forever. It may take that long for an idea or a business premise to fully pay off!
Here's Why CRISPR Therapeutics AG (CRSP) Fell More Than Broader Market
07:01pm, Monday, 07'th Jul 2025
The latest trading day saw CRISPR Therapeutics AG (CRSP) settling at $51.19, representing a -1.88% change from its previous close.
2 Beaten-Down Stocks With Massive Upside Potential
07:00am, Thursday, 03'rd Jul 2025
There are many promising corporations that investors can buy on a dip due to recent market volatility or company-specific issues that predate this year. Take, for instance, CRISPR Therapeutics (CRSP 6
2 Growth Stocks to Buy Hand Over Fist in July
04:01am, Wednesday, 02'nd Jul 2025
July kicks off the latter half of 2025, and the first six months of this year have been eventful, to say the least.
CRISPR Therapeutics AG (CRSP) is Attracting Investor Attention: Here is What You Should Know
10:00am, Monday, 30'th Jun 2025
CRISPR Therapeutics (CRSP) has received quite a bit of attention from Zacks.com users lately. Therefore, it is wise to be aware of the facts that can impact the stock's prospects.
Is CRISPR Therapeutics (CRSP) a Buy as Wall Street Analysts Look Optimistic?
10:31am, Friday, 27'th Jun 2025
When deciding whether to buy, sell, or hold a stock, investors often rely on analyst recommendations. Media reports about rating changes by these brokerage-firm-employed (or sell-side) analysts often
-New Phase 1 clinical data for CTX310™ continues to demonstrate dose-dependent reductions in triglycerides (TG) and low-density lipoprotein (LDL), with peak reduction of up to 82% in TG and up to 86
CRISPR Therapeutics vs. Intellia: Which Gene Editing Stock Holds More Potential?
11:05am, Wednesday, 25'th Jun 2025
CRSP edges ahead of NTLA with the only approved CRISPR therapy, stronger pipeline breadth and recent stock gains.
CRISPR Therapeutics AG (CRSP) Surpasses Market Returns: Some Facts Worth Knowing
07:01pm, Tuesday, 24'th Jun 2025
In the latest trading session, CRISPR Therapeutics AG (CRSP) closed at $46.78, marking a +2.7% move from the previous day.
The Best Stocks to Invest $1,000 in Right Now
04:17am, Tuesday, 24'th Jun 2025
Is it time to reload your portfolio with some new picks? That's easier said than done right now.
The Big 3: CRSP, OKLO, GME
12:01pm, Monday, 23'rd Jun 2025
Mike Shorr (@ProsperTradingAcademy) looks to manage risk levels in his 3 example options trades. For Crispr Therapeutics (CRSP), he's looking at low-implied volatility in the gene-editing biotech comp
2 Biotech Stocks to Buy Before They Soar 84% and 240%, According to Certain Wall Street Analysts
06:10pm, Saturday, 21'st Jun 2025
If you're looking to add growth to your portfolio, biotech stocks can be a great choice. Exciting research is happening in these companies' labs, and in some cases, game-changing treatment candidates
